Wells Fargo
CCXI

Wells Fargo’s ChemoCentryx, Inc. CCXI Stock Holding History

Wells Fargo’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100
Closed -$2K – 8176
2021
Q3 		$2K Sell
100
-87,400
-100% -$1.36M ﹤0.01% 6627
2021
Q2 		$1.17M Buy
+87,500
New +$2.16M ﹤0.01% 4103

Other funds holding CCXI

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Wells Fargo's CCXI Position: Q4 2022 in Review

Wells Fargo sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 3,502 shares — an estimated $181K sold.

Wells Fargo first reported a position in CCXI in Q2 2014 and held it in 34 quarters. The position peaked at $16M in Q4 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Wells Fargo reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Wells Fargo sold 3,502 ChemoCentryx, Inc. shares in Q4 2022, an estimated $181K.
  • Wells Fargo first reported a position in ChemoCentryx, Inc. in Q2 2014 and held it in 34 quarters.
  • Wells Fargo's ChemoCentryx, Inc. position peaked at $16M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Wells Fargo's 13F filing for Q4 2022, filed 13 Feb 2023.